Agios Pharmaceuticals, Inc.
AGIO
Revenue
10.73M
▲1.77M▲19.70%
3 Months ChangeAssets
1.66B
▼-128.60M▼-7.18%
3 Months ChangeLiabilities
122.24M
▼-42.88M▼-25.97%
3 Months ChangeFree Cash Flow
-100.01M
▼-4.43M▼-4.63%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0001439222-24-000138
2024-10-31
Form 8-K
ID: 0001439222-24-000136
2024-08-01
Form 10-Q
ID: 0001439222-24-000121
2024-08-01
Form 8-K
ID: 0001439222-24-000117
2024-06-20
Form 8-K
ID: 0001193125-24-164555
2024-05-28
Form 8-K
ID: 0001193125-24-147583
2024-05-02
Form 10-Q
ID: 0001439222-24-000069
2024-05-02
Form 8-K
ID: 0001439222-24-000067
2024-02-15
Form 8-K
ID: 0001439222-24-000032
2024-01-08
Form 8-K
ID: 0001193125-24-003920